News Industry News Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg April 05, 2018
News Industry News BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode December 08, 2015